tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GNNSF Stock Latest News

Genscript Biotech Schedules Board Meeting to Approve 2024 Results
Company AnnouncementsGenscript Biotech Schedules Board Meeting to Approve 2024 Results
5d ago
Genscript Biotech Reports Substantial Profit Growth in 2024
PremiumCompany Announcements
Genscript Biotech Reports Substantial Profit Growth in 2024
16d ago
Genscript Biotech Strengthens Governance with New Committee
PremiumCompany Announcements
Genscript Biotech Strengthens Governance with New Committee
18d ago
Genscript Biotech Enhances Risk Management with New Sub-Committee
PremiumCompany Announcements
Genscript Biotech Enhances Risk Management with New Sub-Committee
22d ago
Legend Biotech Reports Strong CARVYKTI® Sales for Q4 2024
PremiumCompany Announcements
Legend Biotech Reports Strong CARVYKTI® Sales for Q4 2024
1M ago
Genscript Biotech Boosts Stake in Probio Cayman
PremiumCompany AnnouncementsGenscript Biotech Boosts Stake in Probio Cayman
2M ago
Genscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
Premium
Company Announcements
Genscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
3M ago
Genscript Biotech Announces CEO Resignation and Leadership Changes
Premium
Company Announcements
Genscript Biotech Announces CEO Resignation and Leadership Changes
3M ago
Genscript Biotech Aligns Interests with Restricted Share Grant
PremiumCompany Announcements
Genscript Biotech Aligns Interests with Restricted Share Grant
3M ago
Genscript Biotech Strikes Lucrative Licensing Deal
PremiumCompany Announcements
Genscript Biotech Strikes Lucrative Licensing Deal
4M ago
Genscript Biotech Strengthens Board with New Appointment
PremiumCompany Announcements
Genscript Biotech Strengthens Board with New Appointment
4M ago
Genscript Biotech Reveals Board Composition and Strategy
PremiumCompany Announcements
Genscript Biotech Reveals Board Composition and Strategy
4M ago
Genscript Reports on Legend Biotech’s Q3 Financials
PremiumCompany AnnouncementsGenscript Reports on Legend Biotech’s Q3 Financials
4M ago
Genscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
Premium
Company Announcements
Genscript Biotech’s CARVYKTI Shows Promise in Myeloma Treatment
4M ago
Genscript Biotech Announces Deconsolidation of Legend Biotech
Premium
Company Announcements
Genscript Biotech Announces Deconsolidation of Legend Biotech
4M ago
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
PremiumCompany Announcements
Genscript Biotech Reports Strong CARVYKTI® Sales Growth
5M ago
Genscript’s Breakthrough in Multiple Myeloma Treatment
PremiumCompany Announcements
Genscript’s Breakthrough in Multiple Myeloma Treatment
5M ago
Genscript Biotech Announces Subsidiary’s AGM Date
PremiumCompany Announcements
Genscript Biotech Announces Subsidiary’s AGM Date
5M ago
Genscript Biotech Welcomes New Directors
PremiumCompany Announcements
Genscript Biotech Welcomes New Directors
6M ago
Genscript Biotech Reveals Board Structure
PremiumCompany AnnouncementsGenscript Biotech Reveals Board Structure
6M ago
Legend Biotech announces cilta-cel approval in China for multiple myeloma
Premium
The Fly
Legend Biotech announces cilta-cel approval in China for multiple myeloma
6M ago
LEGN
Genscript Biotech’s New Drug Approval Sparks Interest
Premium
Company Announcements
Genscript Biotech’s New Drug Approval Sparks Interest
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >